Regularly featured on some of the main media networks including Bloomberg TV, Fox Business News and CNBC, Paul Mampilly has become a household name to many viewers. His reputation, however, as one of the most insightful investment advisors is not built solely on his media appearances. His great knowledge and long experience in the financial sector has made him one of the most sought-after professionals in the world of investment today.
A Strong Foundation
Paul graduated from Montclair State University with a BBA in Finance and Accounting. Later, he earned his Finance MBA from the Fordham Graduate School of Business. Among the firms he worked for in the early years of his career are Bankers Trust (where he was a portfolio manager), ING, Deutsche Bank, and Royal Bank of Scotland.
A Rising Star
Many companies with billions of dollars under their fold soon realized Paul’s great potential in bringing huge profits to their establishments. Among the firms that were lucky to have him with them is the Kinetics Asset Management. While handling its hedge funds, Paul managed to raise the value of the company’s assets to the 25-billion-dollar mark. This achievement in return was named by Barron as one of the best in the world. Read more on Crunchbase.com
After working on Wall Street, Paul soon had enough of it. He realized that while he was doing great with the big companies, he was at the same time neglecting the small individual investor as well as spending little time with his family. Today, he has not only won a reputation as one of the most celebrated investment analysts who has helped many investors gain huge profits but also gets to spend a lot more time with his family.
Paul Mampilly may have left Wall Street but his star as one of the greatest investment advisors to walk the earth continues to shine. He founded Profits Unlimited, a company through which he offers valuable advice to people who would like to invest in tech stocks with the aim of helping them earn big while avoiding loss. Leading by example, he has made many investments including in Sarepta Therapeutics, a drug development company, from which he walked away with a 2,500 percent gain. He also realized huge gains from investing in Netflix. Among the prestigious awards he has taken home is the Templeton Foundation investment competition.